CKD Bio Corp. (KRX: 063160)

CKD Bio Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep 30, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	7,277	4,655	3,466	1,463	4,493	11,950
Short-Term Investments	5,069	8,069	69.03	69.99	71.58	4,856
Cash & Short-Term Investments	12,347	12,724	3,535	1,533	4,564	16,806
Cash Growth	1814.78%	259.97%	130.54%	-66.41%	-72.84%	-2.12%
Accounts Receivable	44,402	25,897	29,095	23,986	40,773	29,619
Other Receivables	280.84	1,571	811.09	1,356	2,387	1,436
Receivables	44,683	27,468	29,906	25,342	43,160	31,055
Inventory	71,934	78,507	70,356	59,111	31,438	28,402
Prepaid Expenses	3,065	417	484.92	332.45	283.04	658.05
Other Current Assets	4,058	4,348	60.1	2,063	596.67	1,342
Total Current Assets	136,087	123,464	104,342	88,382	80,042	78,264
Property, Plant & Equipment	174,759	181,509	191,153	191,189	150,832	104,101
Long-Term Investments	2,004	2,004	4.2	4.2	7.2	7.2
Other Intangible Assets	5,874	3,839	2,773	2,921	1,869	1,905
Long-Term Accounts Receivable	-0	0	0	-0	0	226.72
Long-Term Deferred Tax Assets	815.7	-	-	-	-	-
Long-Term Deferred Charges	-	-	-	-	342	15.05
Other Long-Term Assets	632.25	1,775	268.32	966.12	255.35	-0
Total Assets	320,172	312,591	298,540	283,463	233,348	184,520
Accounts Payable	9,679	8,232	9,946	7,822	7,030	5,788
Accrued Expenses	7,635	6,037	5,152	4,479	4,127	3,164
Short-Term Debt	35,688	45,700	12,920	19,247	7,400	2,800
Current Portion of Long-Term Debt	22,700	10,600	6,401	-	56.4	56.4
Current Portion of Leases	730.27	715.33	710.22	715.59	680.48	-
Current Income Taxes Payable	-	-	-	325.69	3,073	696.84
Other Current Liabilities	10,825	10,307	9,181	13,525	22,656	11,130
Total Current Liabilities	87,257	81,591	44,311	46,114	45,024	23,636
Long-Term Debt	98,863	80,373	89,269	59,200	19,000	2,056
Long-Term Leases	1,146	1,537	79.2	681.69	1,239	-
Long-Term Deferred Tax Liabilities	-	118.78	1,480	7,741	7,240	7,659
Other Long-Term Liabilities	1,324	1,172	1,064	978.33	941.72	587.53
Total Liabilities	188,590	164,792	137,049	114,715	74,885	36,858
Common Stock	13,715	13,715	13,715	13,715	13,074	13,074
Additional Paid-In Capital	29,501	29,501	29,501	29,501	27,389	27,389
Retained Earnings	87,738	103,800	118,866	125,919	120,039	109,239
Treasury Stock	-	-	-	-	-1,640	-1,640
Comprensive Income & Other	627.4	782.99	-590.46	-386.93	-398.68	-400
Shareholders' Equity	131,582	147,799	161,491	168,748	158,463	147,662
Total Liabilities & Equity	320,172	312,591	298,540	283,463	233,348	184,520
Total Debt	159,127	138,925	109,379	79,844	28,376	4,913
Net Cash (Debt)	-146,780	-126,201	-105,844	-78,311	-23,812	11,893
Net Cash Per Share	-26756.44	-23004.34	-19293.66	-14474.11	-4421.14	2208.19
Filing Date Shares Outstanding	5.49	5.49	5.49	5.49	5.13	5.39
Total Common Shares Outstanding	5.49	5.49	5.49	5.49	5.39	5.39
Working Capital	48,830	41,874	60,031	42,268	35,018	54,628
Book Value Per Share	23985.21	26941.40	29437.20	30759.97	29421.56	27416.15
Tangible Book Value	125,708	143,960	158,718	165,827	156,594	145,756
Tangible Book Value Per Share	22914.42	26241.61	28931.74	30227.52	29074.53	27062.41
Land	58,753	58,753	58,753	58,753	58,753	50,958
Buildings	111,358	111,339	112,056	105,063	42,335	41,905
Machinery	182,866	179,305	172,468	159,281	125,958	121,872
Construction In Progress	1,651	399.75	1,089	10,575	54,490	13,427

Source: S&P Capital IQ. Standard template. Financial Sources.